The SLC22A1 gene gives liver cells instructions for a transporter that moves certain natural body chemicals and some medicines from the blood into cells. If this transporter works less well, your body may handle drugs such as metformin differently, which can affect benefit or side effects. Most variants in this gene do not cause a disease on their own, but some can influence how treatment works. This gene can play a role in how your body responds to common medicines used for diabetes and other conditions.
What is a gene?
Genes are stretches of DNA that give your cells instructions to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do the work. Other genes are used mainly to control when certain processes happen, where they happen, and how strongly they occur. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
SLC22A1Gene function
What if the gene works
The SLC22A1 gene helps liver cells move certain medicines and natural body chemicals from the blood into the cell. This supports how your body processes and clears some substances.
Risk
What if the gene does not work
Milder to more severe variants in the SLC22A1 gene can reduce or stop OCT1 transporter activity in liver cells. This changes how cells take up certain positively charged compounds, including some medicines and natural body chemicals.
Treatment
What does that mean for your treatment
A pathogenic or loss-of-function variant in the SLC22A1 gene does not currently lead to a guideline-based, SLC22A1-specific treatment or management change. The SLC22A1 gene is being studied as a drug-response biomarker, especially for metformin and some other medicines that use the OCT1 transporter, but this has not led to routine treatment decisions.
Gene function
What if the gene works
Your liver uses the SLC22A1 gene to bring certain small, positively charged substances from the blood into cells. This supports everyday chemical handling, including natural body compounds and some outside substances. Understanding how the SLC22A1 gene works helps explain how the liver starts processing materials that circulate through the body.
The SLC22A1 gene makes a transporter on the surface of liver cells. It moves selected small, positively charged molecules from the bloodstream into the cell.
Its protein acts like a shuttle, carrying chosen molecules across the cell membrane. This gives liver cells a controlled way to take in substances that do not pass inside easily on their own.
By bringing these substances into liver cells, this gene supports an early step in how the body handles them. That helps the liver work through normal body chemicals and many outside compounds in a steady way.
What is a variant?
A genetic variant is a minor change in the DNA sequence of a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant changes how a gene works more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC22A1 gene can change the OCT1 transporter so it folds poorly, reaches the cell surface in lower amounts, or moves positively charged molecules less efficiently. In practical terms, how SLC22A1 variants affect transporter function depends on the change: some mildly reduce transport activity, while more severe variants can nearly abolish uptake. Certain variants also alter which molecules OCT1 recognizes or how stable the protein remains inside the cell.
How variants are linked to conditions
Current research on SLC22A1 gene variants and health conditions has not established a broadly confirmed link to one specific condition, and reported findings have varied across studies. Anyone with a confirmed SLC22A1-related diagnosis should rely on guidance from their doctor or genetic counselor for interpretation tailored to their health history.
A variant is not necessarily a diagnosis
Variants in DNA are a routine part of human biology and are common throughout the general population. Most do not directly affect health and instead reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when multiple genes and environmental factors also play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the SLC22A1 gene itself. SLC22A1 is better known for affecting how some medicines move through the body, so anyone concerned about personal risk should speak with a doctor or genetic counselor.
Inheritance of SLC22A1 variants
There is not yet a broadly confirmed Mendelian pattern for how SLC22A1 gene variants are inherited in relation to a specific disease, because this gene is most often discussed for differences in drug handling rather than a single inherited condition. For people looking into how SLC22A1 gene variants are inherited, SLC22A1 is located on chromosome 6, which is an autosome. That means you inherit one copy of the SLC22A1 gene from each parent.
What does my SLC22A1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific health condition for SLC22A1. If you have an SLC22A1 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can explain it in the context of your exact result and any family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the SLC22A1 gene, a lab can do genetic testing for SLC22A1 variants using a blood, saliva, or cheek swab sample. The sample’s DNA is read to look for changes in the gene, and the report shows which variants were found.
When should I consider getting a genetic test?
There is not yet a broadly established reason to get a genetic test just for the SLC22A1 gene. Decisions about testing are usually based on your overall health, medicines, and family history, and are best discussed with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic result can provide valuable insight, but how much it explains depends on the condition and on the type of variant involved. Over time, the way the body works is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best interpreted alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, seem less effective for another, or cause more side effects in someone else. Part of the reason is that inherited differences can change how the body absorbs, moves, breaks down, or clears a medicine. These differences are common and can influence both treatment benefit and sensitivity to a drug.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medicines. By studying links between genes and medications, it helps explain why the same treatment may not work in the same way for everyone. With many drugs, genes can influence how powerfully a medicine works or how the body handles it. Understanding this can support treatment choices that are more informed and more tailored to the individual. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC22A1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding routine medication choices, so questions about side effects, how well a medicine is working, or medication changes are best discussed with your doctor. SLC22A1 has been studied for how some people respond to metformin, a common diabetes medicine, but this has not become standard guidance for treatment.
History
Researchers identified the SLC22A1 gene in the 1990s while mapping transport proteins that move small charged molecules into cells. It was first described as the gene for organic cation transporter 1, or OCT1, and this helped connect earlier lab findings to a specific human gene. From these first observations, research expanded steadily. Studies in the following years showed that inherited variants in the SLC22A1 gene can change how people handle certain medicines, which made it an important part of pharmacogenetics research. Its history is tied less to public attention and more to steady progress in drug response science. Today, the SLC22A1 gene is mainly known through this research path, especially in work on metformin and other commonly used drugs.